当前位置:首页 - 行情中心 - 普洛药业(000739) - 财务分析 - 现金流量表

普洛药业

(000739)

  

流通市值:177.08亿  总市值:177.15亿
流通股本:11.69亿   总股本:11.69亿

现金流量表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金7,470,804,774.825,192,153,998.212,298,162,652.028,862,726,155.21
收到的税费返还377,272,002.48247,591,936.77119,072,429.83484,128,759.81
收到其他与经营活动有关的现金235,141,089.55134,817,924.1645,145,765.24328,214,960.87
经营活动现金流入的平衡项目0000
经营活动现金流入小计8,083,217,866.855,574,563,859.142,462,380,847.099,675,069,875.89
购买商品、接受劳务支付的现金5,241,010,944.553,404,063,083.551,484,349,282.756,458,584,615.38
支付给职工以及为职工支付的现金668,301,144.09487,665,390.82310,068,540.29941,813,373.09
支付的各项税费408,642,692.37326,140,618.77191,187,769.34481,246,056.29
支付其他与经营活动有关的现金599,553,971375,913,491.52196,649,780.84762,062,757.05
经营活动现金流出的平衡项目0000
经营活动现金流出小计6,917,508,752.014,593,782,584.662,182,255,373.228,643,706,801.81
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额1,165,709,114.84980,781,274.48280,125,473.871,031,363,074.08
二、投资活动产生的现金流量:
收回投资收到的现金209,817,558.38--52,102,285.56
处置固定资产、无形资产和其他长期资产收回的现金净额2,140,8791,311,425.61-8,961,893.47
处置子公司及其他营业单位收到的现金净额7,600,0007,600,0007,600,00030,399,153.01
收到的其他与投资活动有关的现金23,888,979.9723,819,070.2-35,153,034.98
投资活动现金流入的平衡项目0000
投资活动现金流入小计243,447,417.3532,730,495.817,600,000126,616,367.02
购建固定资产、无形资产和其他长期资产支付的现金370,821,462.29225,470,429.51195,490,715.85630,467,013.51
投资支付的现金205,532,427.566,000,000-130,000,000
支付其他与投资活动有关的现金31,631,603.7122,527,412.28251,425.242,947,298.18
投资活动现金流出的平衡项目0000
投资活动现金流出小计607,985,493.56253,997,841.79195,742,141.05803,414,311.69
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-364,538,076.21-221,267,345.98-188,142,141.05-676,797,944.67
三、筹资活动产生的现金流量:
吸收投资收到的现金505,050505,050-375,000
其中:子公司吸收少数股东投资收到的现金505,050505,050-375,000
取得借款收到的现金1,005,000,000530,000,000260,000,0001,061,180,916.67
筹资活动现金流入平衡项目0000
筹资活动现金流入小计1,005,505,050530,505,050260,000,0001,061,555,916.67
偿还债务支付的现金974,844,000463,944,000210,000,000964,665,668.05
分配股利、利润或偿付利息支付的现金400,949,056.95392,174,429.9211,718,538.9383,021,977.07
支付其他与筹资活动有关的现金162,242,683.59152,684,774.7761,415.715,352,107.23
筹资活动现金流出平衡项目0000
筹资活动现金流出小计1,538,035,740.541,008,803,204.62222,479,954.61,363,039,752.35
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-532,530,690.54-478,298,154.6237,520,045.4-301,483,835.68
四、汇率变动对现金及现金等价物的影响4,431,426.1331,181,409.147,083,124.5127,492,395.93
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额273,071,774.22312,397,183.02136,586,502.7380,573,689.66
加:期初现金及现金等价物余额2,462,485,761.742,462,485,761.742,462,485,761.742,381,912,072.08
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额2,735,557,535.962,774,882,944.762,599,072,264.472,462,485,761.74
补充资料:
净利润-624,645,137.35-1,055,306,898.23
资产减值准备-92,493,877.92-106,487,344.7
固定资产和投资性房地产折旧-271,502,187.29-538,031,286.28
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-271,502,187.29-538,031,286.28
无形资产摊销-5,569,667.1-15,026,434.82
长期待摊费用摊销-3,651,259.63-5,926,894.02
处置固定资产、无形资产和其他长期资产的损失--567,328.49--1,328,848.13
固定资产报废损失-1,244,290.9-7,793,162.14
公允价值变动损失-2,535,659.78-19,228.93
财务费用--46,536,961.35-60,329,518.38
投资损失-723,423.58-18,064,111.37
递延所得税-15,099,049.09-3,643,266.88
其中:递延所得税资产减少-24,612,161.01-22,889,492.3
递延所得税负债增加--9,513,111.92--19,246,225.42
存货的减少-332,492,337.48--373,347,043.74
经营性应收项目的减少--650,389,770.25--571,625,127.25
经营性应付项目的增加-321,711,320.17-130,168,077.8
其他---36,867,869.65
现金的期末余额-2,774,882,944.76-2,462,485,761.74
减:现金的期初余额-2,462,485,761.74-2,381,912,072.08
公告日期2024-10-182024-08-162024-04-182024-03-08
审计意见(境内)标准无保留意见
TOP↑